Skip to main content
. 2017 Jun 29;4(1):e000173. doi: 10.1136/lupus-2016-000173

FigureĀ 3.

FigureĀ 3

Longer duration of clinical remission is associated with increased likelihood of withdrawal of prednisolone and ISS drugs in a patient with SLE with previous major organ involvement and current normal serology. The four scenarios vary according to serological abnormality. N/N, normal dsDNA/normal complement; P/N, abnormal dsDNA/normal complement; N/P, normal dsDNA/abnormal complement; P/P, abnormal dsDNA/abnormal complement; ISS, immunosuppressive.